Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.
Date
2011Author
Machiels, J. H.
Ozguroglu, M.
Hansen, S.
Shen, L.
De Bono, J. S.
Oudard, S.
Sartor, A. O.
Metadata
Show full item recordCollections
- Makale [92796]